Microdroplets may reduce colorectal tumor growth at potentially lower cost

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed microscopic peptide droplets that deliver large amounts of gene-silencing molecules into cancer and immune cells, reducing the growth of hard-to-treat colorectal tumors by about 67% in mice. The patent-pending system uses small interfering RNA, or siRNA, to disrupt the production of two proteins that cancer cells exploit to evade attacks by the immune system.

Read it at Medical Xpress ↗

← Front page